Department OverviewThe OHSU Knight Cancer Institute is a world leader in treating leukemia. Our director, Dr. Brian Druker, is an internationally recognized pioneer in precision cancer medicine. Dr. Druker played a central role in developing Gleevec, a daily pill for chronic myelogenous leukemia (CML) that has saved tens of thousands of lives. Now he is helping lead Beat AML, a major effort to find better treatments for acute myeloid leukemia. Every Knight Cancer employee is expected to embody our guiding principles: We act BOLDLY--Breakthroughs require pushing the boundaries of science, exploring new frontiers, and thinking differently We SUPPORT each other--Respect leads to trust, which leads to excellence We work as a C
This job listing is no longer active.
Check the left side of the screen for similar opportunities.